Gynaecological cancer incidence is increasing in number. There are many initiatives to reduce gynaecological cancers, such as cervical screening, the HPV vaccine and prophylactic surgery for BRCA1/2 Mutation carriers. However, with a growing and aging population, like many other cancer specialities, we will continue to see increasing numbers of cases.
In Ireland, the most common gynaecological cancer is uterine/endometrial carcinoma (550 cases/year). Followed by ovarian (400 cases/year, cervical (300 cases/year) and vulval/vaginal/other (170 cases/year).
Our service has seen an increase in activity and through our combines sites of MMUH & SVUH care for nearly 400 new cases each year alongside cases of recurrent cancer. The majority of cases require both surgical and medical treatments.
| Cancer Site |
2018 |
2019 |
2020 (January – August) |
| Endometrial/Uterine |
139 |
133 |
72 |
| Ovary |
102 |
148 |
103 |
| Cervix |
46 |
50 |
27 |
| Vulval/Vaginal |
19 |
29 |
17 |
| TOTAL |
306 |
364 |
219 |
The treatment pathway of each patient is personalised by our multidisciplinary team meeting (MDT), which is held weekly in the Mater Hospital and fortnightly in St Vincent’s Hospital.
Referral information to both MDTs can be found at individual websites
St. Vincent's University Hospital - Gynaecology
Mater Misericordiae University Hospital - Gynaecological Oncology
|
|
2018 |
2019 |
2020 January - Sept |
| New MDT Referrals |
716 |
757 |
631 |
| Total MDT Discussions |
989 |
1215 |
1131 |